BioVersys AG | WebDisclosure

Basculer en Français

9478	Companies
185482	Keywords
117825	Articles
99322	Press releases

Home
Companies
BioVersys AG

PRESS RELEASE

published on 08/27/2025 at 07:00, 3 months 9 days ago

BioVersys receives EMA Orphan Designation for the combination of alpibectir and ethionamide for the treatment of tuberculosis
BioVersys receives EMA Orphan Designation for the combination of alpibectir and ethionamide for the treatment of tuberculosis. The designation provides key incentives for addressing drug resistance in TB treatment

BioVersys Tuberculosis Alpibectir EMA Orphan Designation Ethionamide
BRIEF

published on 07/02/2025 at 07:05, 5 months 3 days ago

BioVersys et Shionogi collaborent sur le candidat clinique NTM

Commercialisation Mondiale Collaboration BioVersys Partenariat Shionogi Candidat Clinique NTM Plateforme Ansamycine
BRIEF

published on 07/02/2025 at 07:05, 5 months 3 days ago

BioVersys and Shionogi Collaborate on NTM Clinical Candidate

Global Commercialization BioVersys Collaboration Shionogi Partnership NTM Clinical Candidate Ansamycin Platform
PRESS RELEASE

published on 07/02/2025 at 07:00, 5 months 3 days ago

BIOVERSYS AND SHIONOGI ENTER INTO GLOBAL RESEARCH COLLABORATION FOR BROAD-SPECTRUM NON-TUBERCULOUS MYCOBACTERIA (NTM) CLINICAL CANDIDATE
BioVersys and Shionogi enter global research collaboration for NTM clinical candidate. BioVersys grants Shionogi license option for leads from BV500 program

Shionogi BioVersys Global Research Collaboration NTM Clinical Candidate
BRIEF

published on 06/30/2025 at 07:05, 5 months 5 days ago

L'assemblée générale annuelle de BioVersys AG donne des résultats positifs

États Financiers Élections Du Conseil D'administration Initiatives Stratégiques Assemblée Générale Annuelle De BioVersys Amendement Capital
BRIEF

published on 06/30/2025 at 07:05, 5 months 5 days ago

BioVersys AG Annual General Meeting Yields Positive Outcomes

Financial Statements Strategic Initiatives Board Elections BioVersys AGM Capital Amendment
PRESS RELEASE

published on 06/30/2025 at 07:00, 5 months 5 days ago

BIOVERSYS ANNOUNCES RESULTS FROM its ANNUAL GENERAL MEETING OF SHAREHOLDERS
BioVersys AG announces results from its Annual General Meeting of Shareholders, including re-election of Board Members and amendment to capital range for strategic initiatives

Annual General Meeting Shareholders Board Members BioVersys AG Capital Range
BRIEF

published on 06/03/2025 at 07:05, 6 months 2 days ago

BioVersys Announces 2025 Annual General Meeting of Shareholders

Capital Increase Board Elections Shareholders Meeting 2025 AGM BioVersys AG
BRIEF

published on 06/03/2025 at 07:05, 6 months 2 days ago

BioVersys annonce l'assemblée générale annuelle des actionnaires de 2025

Augmentation De Capital Élections Du Conseil D'administration Assemblée Générale Des Actionnaires Assemblée Générale Annuelle 2025 BioVersys AG
PRESS RELEASE

published on 06/03/2025 at 07:00, 6 months 2 days ago

BioVersys publishes Invitation to its ANNUAL GENERAL MEETING OF SHAREHOLDERS 2025
BioVersys AG publishes Invitation to its Annual General Meeting of Shareholders 2025, including agenda with items such as annual report, elections, compensation approval, and capital range amendment

Annual General Meeting Shareholders Biopharmaceutical AGM 2025 BioVersys AG

Accesswire

Published on 12/05/2025 at 15:25, 9 minutes ago

Usha Resources Provides Corporate Updates
Published on 12/05/2025 at 15:00, 34 minutes ago

Calidi Biotherapeutics and Nova Minerals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Published on 12/05/2025 at 14:00, 1 hour 34 minutes ago

Ocean Power Technologies Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 14:00, 1 hour 34 minutes ago

Bonk, Inc. Highlights Major Ecosystem Milestone: Launch of Regulated BONK ETP on SIX Swiss Exchange
Published on 12/05/2025 at 02:35, 12 hours 59 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 15:05, 29 minutes ago

Seegene Establishes French Subsidiary to Expand European Footprint
Published on 12/05/2025 at 14:22, 1 hour 11 minutes ago

EQS-Adhoc: Jungheinrich AG: Jungheinrich expects to complete sale of its Russian subsidiary in 2026 and adjusts forecast for the 2025 financial year
Published on 12/05/2025 at 14:16, 1 hour 17 minutes ago

Advanced Blockchain AG: Successful Completion of Token Generation Event of Portfolio company Talisman
Published on 12/05/2025 at 14:10, 1 hour 24 minutes ago

The Kingdom of Saudi Arabia Launches a New Official Platform, "Saudi Properties", Ahead of the Non-Saudi Property Ownership Law
Published on 12/05/2025 at 13:45, 1 hour 49 minutes ago

BingX Introduces Recurring Buy to Help Users Ride Out Crypto Market Swings

Les Echos

Published on 12/05/2025 at 15:10, 23 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 23 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 1 hour 35 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE
Published on 12/05/2025 at 08:45, 6 hours 49 minutes ago

Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 6 hours 49 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry

View all LES ECHOS COMFI WIRE